Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
CONCLUSIONS: We have presented a case of spontaneous clearance of HCV-RNA after splenectomy in a patient with cirrhosis and portal hypertension. Splenectomy may be associated with disappearance of HCV-RNA based on previous reports. More cases should be accumulated and evaluated.PMID:38647617 | DOI:10.1186/s40792-024-01899-6 (Source: Hand Surgery)
Source: Hand Surgery - April 22, 2024 Category: Surgery Authors: Toshiro Ogata Terufumi Sakai Sho Shibata Hiroki Kanno Hiroyuki Nakane Takeshi Aoyagi Kazuhiro Koikawa Yoshihiko Sadakari Gentaro Hirokata Masahiko Taniguchi Source Type: research
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma
In conclusion, targeting Claudin proteins offers a novel clinical opportunity for the treatment of patients with advanced liver fibrosis and HCC. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | Full text (Source: Seminars in Liver Disease)
Source: Seminars in Liver Disease - April 22, 2024 Category: Gastroenterology Authors: Saviano, Antonio Roehlen, Natascha Baumert, Thomas F. Tags: Review Article Source Type: research
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 –2019
Between 2013 –2019, several all-oral direct-acting antivirals (DAAs) were launched with the potential to cure patients with hepatitis C virus (HCV). They generated economic value in terms of the health gains for patients and cost-savings for the US healthcare system. We estimated the share of this value alloca ted to four manufacturers vs society. (Source: Value in Health)
Source: Value in Health - April 22, 2024 Category: International Medicine & Public Health Authors: Louis P. Garrison, Boshen Jiao, Zizi Elsisi, Alon Yehoshua, Roy Koruth, Bruce Kreter, Jens Grueger Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Communicable Disease Screening and Human Immunodeficiency Virus Prevention in the Emergency Department
Emerg Med Clin North Am. 2024 May;42(2):369-389. doi: 10.1016/j.emc.2024.02.007. Epub 2024 Mar 19.ABSTRACTEmergency departments (ED) provide care to populations with high rates of communicable diseases, like HIV, hepatitis C virus, and syphilis. For many patients, the ED is their sole entry point into the healthcare system and they do not routinely access screening and prevention services elsewhere. As such, the ED can serve an important public health role through communicable disease identification, treatment, and prevention. In this article, we examine national recommendations, peer-reviewed literature, and expert consen...
Source: The Medical Clinics of North America - April 19, 2024 Category: General Medicine Authors: Douglas A E White Rachel E Solnick Source Type: research
Trends in Mortality Related to Hepatitis B and C from 1990 to 2019 in the Western Pacific Region
CONCLUSIONS: : Although the mortality rate from hepatitis B and C decreased from 1990 to 2019, notable variation was observed among 27 Western Pacific countries. Efforts targeting hepatitis B and C prevention and treatment are still required in this region, especially for the pandemic countries.PMID:38638100 | DOI:10.5009/gnl230023 (Source: Gut and Liver)
Source: Gut and Liver - April 19, 2024 Category: Gastroenterology Authors: Hua Zhou Mengxia Yan Datian Che Bin Wu Source Type: research
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
CONCLUSION: Metformin for DM and statins for HLP have chemopreventive effects on HCC risk in CHC patients who failed antiviral therapy. These findings emphasize the importance of personalized preventive strategies for managing patients with these clinical profiles.PMID:38637957 | DOI:10.3350/cmh.2024.0038 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 19, 2024 Category: Gastroenterology Authors: Pei-Chien Tsai Chung-Feng Huang Ming-Lun Yeh Meng-Hsuan Hsieh Hsing-Tao Kuo Chao-Hung Hung Kuo-Chih Tseng Hsueh-Chou Lai Cheng-Yuan Peng Jing-Houng Wang Jyh-Jou Chen Pei-Lun Lee Rong-Nan Chien Chi-Chieh Yang Gin-Ho Lo Jia-Horng Kao Chun-Jen Liu Chen-Hua L Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Communicable Disease Screening and Human Immunodeficiency Virus Prevention in the Emergency Department
Emerg Med Clin North Am. 2024 May;42(2):369-389. doi: 10.1016/j.emc.2024.02.007. Epub 2024 Mar 19.ABSTRACTEmergency departments (ED) provide care to populations with high rates of communicable diseases, like HIV, hepatitis C virus, and syphilis. For many patients, the ED is their sole entry point into the healthcare system and they do not routinely access screening and prevention services elsewhere. As such, the ED can serve an important public health role through communicable disease identification, treatment, and prevention. In this article, we examine national recommendations, peer-reviewed literature, and expert consen...
Source: The Medical Clinics of North America - April 19, 2024 Category: General Medicine Authors: Douglas A E White Rachel E Solnick Source Type: research
Trends in Mortality Related to Hepatitis B and C from 1990 to 2019 in the Western Pacific Region
CONCLUSIONS: : Although the mortality rate from hepatitis B and C decreased from 1990 to 2019, notable variation was observed among 27 Western Pacific countries. Efforts targeting hepatitis B and C prevention and treatment are still required in this region, especially for the pandemic countries.PMID:38638100 | DOI:10.5009/gnl230023 (Source: Gut and Liver)
Source: Gut and Liver - April 19, 2024 Category: Gastroenterology Authors: Hua Zhou Mengxia Yan Datian Che Bin Wu Source Type: research
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
CONCLUSION: Metformin for DM and statins for HLP have chemopreventive effects on HCC risk in CHC patients who failed antiviral therapy. These findings emphasize the importance of personalized preventive strategies for managing patients with these clinical profiles.PMID:38637957 | DOI:10.3350/cmh.2024.0038 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - April 19, 2024 Category: Gastroenterology Authors: Pei-Chien Tsai Chung-Feng Huang Ming-Lun Yeh Meng-Hsuan Hsieh Hsing-Tao Kuo Chao-Hung Hung Kuo-Chih Tseng Hsueh-Chou Lai Cheng-Yuan Peng Jing-Houng Wang Jyh-Jou Chen Pei-Lun Lee Rong-Nan Chien Chi-Chieh Yang Gin-Ho Lo Jia-Horng Kao Chun-Jen Liu Chen-Hua L Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Communicable Disease Screening and Human Immunodeficiency Virus Prevention in the Emergency Department
Emerg Med Clin North Am. 2024 May;42(2):369-389. doi: 10.1016/j.emc.2024.02.007. Epub 2024 Mar 19.ABSTRACTEmergency departments (ED) provide care to populations with high rates of communicable diseases, like HIV, hepatitis C virus, and syphilis. For many patients, the ED is their sole entry point into the healthcare system and they do not routinely access screening and prevention services elsewhere. As such, the ED can serve an important public health role through communicable disease identification, treatment, and prevention. In this article, we examine national recommendations, peer-reviewed literature, and expert consen...
Source: The Medical Clinics of North America - April 19, 2024 Category: General Medicine Authors: Douglas A E White Rachel E Solnick Source Type: research
Trends in Mortality Related to Hepatitis B and C from 1990 to 2019 in the Western Pacific Region
CONCLUSIONS: : Although the mortality rate from hepatitis B and C decreased from 1990 to 2019, notable variation was observed among 27 Western Pacific countries. Efforts targeting hepatitis B and C prevention and treatment are still required in this region, especially for the pandemic countries.PMID:38638100 | DOI:10.5009/gnl230023 (Source: Gut and Liver)
Source: Gut and Liver - April 19, 2024 Category: Gastroenterology Authors: Hua Zhou Mengxia Yan Datian Che Bin Wu Source Type: research
